Induction of differentiation of the human leukemia cell line, KU812. 1987

S A Fischkoff, and K Kishi, and W R Benjamin, and R M Rossi, and M C Hoessly, and J A Hoxie, and C Seals, and L Anderson, and T Ishizaka, and J Hakimi
Hematology/Oncology Section, University of Pennsylvania, School of Medicine, Philadelphia 19104.

We treated KU812 cells from different passage levels with compounds which induce differentiation of other leukemic cell lines. Early passages contained small subpopulations of basophil and erythrocyte-like cells, but later passages consisted of more uniform cells with a myelomonocytic phenotype. When cultured with 1 nM actinomycin D, the cells became nonproliferative, developed pale cytoplasm and segmented nuclei, and lost nonspecific esterase activity. Thus, KU812 cells can be induced to mature to cells with a myelomonocytic phenotype. However, their expression of previously reported basophil characteristics diminishes with continued passage, and may be a capability of only a subpopulation of the cells.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations
D013866 Thioguanine An antineoplastic compound which also has antimetabolite action. The drug is used in the therapy of acute leukemia. 6-Thioguanine,2-Amino-6-Purinethiol,Lanvis,Tabloid,Thioguanin-GSK,Thioguanine Anhydrous,Thioguanine Hemihydrate,Thioguanine Monosodium Salt,Thioguanine Tabloid,Tioguanina Wellcome,Tioguanine,2 Amino 6 Purinethiol,6 Thioguanine,Anhydrous, Thioguanine,Thioguanin GSK,ThioguaninGSK
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

S A Fischkoff, and K Kishi, and W R Benjamin, and R M Rossi, and M C Hoessly, and J A Hoxie, and C Seals, and L Anderson, and T Ishizaka, and J Hakimi
September 1988, Scandinavian journal of immunology,
S A Fischkoff, and K Kishi, and W R Benjamin, and R M Rossi, and M C Hoessly, and J A Hoxie, and C Seals, and L Anderson, and T Ishizaka, and J Hakimi
July 2001, Cytotechnology,
S A Fischkoff, and K Kishi, and W R Benjamin, and R M Rossi, and M C Hoessly, and J A Hoxie, and C Seals, and L Anderson, and T Ishizaka, and J Hakimi
June 1998, Biochemical and biophysical research communications,
S A Fischkoff, and K Kishi, and W R Benjamin, and R M Rossi, and M C Hoessly, and J A Hoxie, and C Seals, and L Anderson, and T Ishizaka, and J Hakimi
November 2010, Experimental biology and medicine (Maywood, N.J.),
S A Fischkoff, and K Kishi, and W R Benjamin, and R M Rossi, and M C Hoessly, and J A Hoxie, and C Seals, and L Anderson, and T Ishizaka, and J Hakimi
January 1989, International archives of allergy and applied immunology,
S A Fischkoff, and K Kishi, and W R Benjamin, and R M Rossi, and M C Hoessly, and J A Hoxie, and C Seals, and L Anderson, and T Ishizaka, and J Hakimi
May 1997, Clinical and experimental immunology,
S A Fischkoff, and K Kishi, and W R Benjamin, and R M Rossi, and M C Hoessly, and J A Hoxie, and C Seals, and L Anderson, and T Ishizaka, and J Hakimi
January 1994, Immunology,
S A Fischkoff, and K Kishi, and W R Benjamin, and R M Rossi, and M C Hoessly, and J A Hoxie, and C Seals, and L Anderson, and T Ishizaka, and J Hakimi
January 1986, Haematologia,
S A Fischkoff, and K Kishi, and W R Benjamin, and R M Rossi, and M C Hoessly, and J A Hoxie, and C Seals, and L Anderson, and T Ishizaka, and J Hakimi
May 1980, Proceedings of the National Academy of Sciences of the United States of America,
S A Fischkoff, and K Kishi, and W R Benjamin, and R M Rossi, and M C Hoessly, and J A Hoxie, and C Seals, and L Anderson, and T Ishizaka, and J Hakimi
May 1990, Biochemical and biophysical research communications,
Copied contents to your clipboard!